Nicotine Replacement Therapy for Smoking Cessation During Pregnancy

Description

This review provides an overview of current guidelines regarding NRT (nicotine replacement therapy) use in pregnancy, considering the existing evidence base on safety, efficacy and effectiveness.

In addition, it outlines pragmatic suggestions for clinical practice and implications for policy and future research.

 

 

Learning Outcomes

  1. Develop an understanding of nicotine replacement therapy (NRT), recommended in current   Australian clinical guidelines for pregnant women who are unable to quit smoking unassisted
  2. Become aware of the effects of nicotine on the fetal development in animal models, and the safety and efficacy of nicotine replacement therapy in human studies
  3. Use this review as a practical guide on how the risks versus benefits of NRT use during pregnancy could be articulated, and how and when to decide whether to use or increase NRT during pregnancy

 

Authors: Yael Bar-Zeev, Ling Li Lim, Billie Bonevski, Maree Gruppetta, Gillian S Gould

Article Type: Narrative review

 

Medical Journal of Australia
N/A
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Women's Health
Medical Practitioner, Medical Student, Dentist, Doctor-in-Training, Non-Vocationally Registered, Nurse / Midwife, Pharmacist, Psychologist, Researcher, Retired, Specialist - Other, Specialist General Practitioner
You have to be logged in to see the content of this module.

  • © 2024 AMA (WA)
  • doctorportal Learning
  • ABN: 65 630 316 942
  • 14 Stirling Highway, Nedlands WA 6009, Australia
  • PO Box 133, Nedlands WA 6009
  • E: enquiries@dplearning.com.au

doctorportal Learning respectfully acknowledges Aboriginal and Torres Strait Islander peoples as the first inhabitants of Australia. We respect the traditional owners of lands across Australia in which our members and staff work and live, and pay respect to their elders past, present and emerging.